These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 3143710)
1. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells. Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710 [TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D; Strife A; Atzpodien J; Clarkson BD Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231 [TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor and human hematopoiesis: I. Kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in short-term suspension cultures in vitro. Beran M; O'Brien S; Gutterman JU; McCredie KB Hematol Pathol; 1988; 2(1):31-42. PubMed ID: 3266210 [TBL] [Abstract][Full Text] [Related]
4. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433 [TBL] [Abstract][Full Text] [Related]
5. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165 [TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon. Hahn T; Barak Y; Liebovich E; Malach L; Dagan O; Rubinstein E Exp Hematol; 1991 Mar; 19(3):157-60. PubMed ID: 1899831 [TBL] [Abstract][Full Text] [Related]
7. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574 [TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Murphy M; Perussia B; Trinchieri G Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270 [TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor. Gajewski TF; Goldwasser E; Fitch FW J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726 [TBL] [Abstract][Full Text] [Related]
10. Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor. Hahn T; Shulman LM; Ben-Hur H; Karov Y; Barak V; Handgretinger R; Barak Y Exp Hematol; 1994 Feb; 22(2):114-21. PubMed ID: 8299733 [TBL] [Abstract][Full Text] [Related]
11. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702 [TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V; Ferguson KF; Heller G; Kernan NA Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [TBL] [Abstract][Full Text] [Related]
13. Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons. Beran M; McCredie KB; Keating MJ; Gutterman JU Blood; 1988 Aug; 72(2):728-38. PubMed ID: 3135864 [TBL] [Abstract][Full Text] [Related]
14. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth. Barak Y; Hahn T; Pecht M; Karov Y; Berrebi A; Zaizov R; Stark B; Buchner V; Burstein Y; Trainin N Exp Hematol; 1992 Feb; 20(2):173-7. PubMed ID: 1544385 [TBL] [Abstract][Full Text] [Related]
15. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Aglietta M; Stacchini A; Severino A; Sanavio F; Ferrando ML; Piacibello W Exp Hematol; 1989 Mar; 17(3):296-9. PubMed ID: 2783914 [TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures. Lu L; Welte K; Gabrilove JL; Hangoc G; Bruno E; Hoffman R; Broxmeyer HE Cancer Res; 1986 Sep; 46(9):4357-61. PubMed ID: 3089590 [TBL] [Abstract][Full Text] [Related]